Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Bibliographic Details
Main Authors: Patrick M. Honore, David De Bels, Herbert D. Spapen
Format: Article
Language:English
Published: SpringerOpen 2018-09-01
Series:Annals of Intensive Care
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13613-018-0431-5
_version_ 1811286611035422720
author Patrick M. Honore
David De Bels
Herbert D. Spapen
author_facet Patrick M. Honore
David De Bels
Herbert D. Spapen
author_sort Patrick M. Honore
collection DOAJ
first_indexed 2024-04-13T03:04:00Z
format Article
id doaj.art-3d7c5a9bcdd648dbb4690ac0c26b36b5
institution Directory Open Access Journal
issn 2110-5820
language English
last_indexed 2024-04-13T03:04:00Z
publishDate 2018-09-01
publisher SpringerOpen
record_format Article
series Annals of Intensive Care
spelling doaj.art-3d7c5a9bcdd648dbb4690ac0c26b36b52022-12-22T03:05:20ZengSpringerOpenAnnals of Intensive Care2110-58202018-09-01811310.1186/s13613-018-0431-5Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?Patrick M. Honore0David De Bels1Herbert D. Spapen2ICU Department, Centre Hospitalier Universitaire BrugmannICU Department, Centre Hospitalier Universitaire BrugmannUniversitair Ziekenhuis Brussel, VUB Universityhttp://link.springer.com/article/10.1186/s13613-018-0431-5Astragaloside IVAntioxidant therapyRhabdomyolysisCrush syndromeIschemia–reperfusion injury
spellingShingle Patrick M. Honore
David De Bels
Herbert D. Spapen
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Annals of Intensive Care
Astragaloside IV
Antioxidant therapy
Rhabdomyolysis
Crush syndrome
Ischemia–reperfusion injury
title Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
title_full Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
title_fullStr Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
title_full_unstemmed Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
title_short Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
title_sort beneficial effects of antioxidant therapy in crush syndrome in a rodent model enough evidences to be used in humans
topic Astragaloside IV
Antioxidant therapy
Rhabdomyolysis
Crush syndrome
Ischemia–reperfusion injury
url http://link.springer.com/article/10.1186/s13613-018-0431-5
work_keys_str_mv AT patrickmhonore beneficialeffectsofantioxidanttherapyincrushsyndromeinarodentmodelenoughevidencestobeusedinhumans
AT daviddebels beneficialeffectsofantioxidanttherapyincrushsyndromeinarodentmodelenoughevidencestobeusedinhumans
AT herbertdspapen beneficialeffectsofantioxidanttherapyincrushsyndromeinarodentmodelenoughevidencestobeusedinhumans